During the past decade, Nashville Gastrointestinal Specialists Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nashville Gastrointestinal Specialists Inc." #1 sponsor was "Gilead Sciences" with 12 trials, followed by "Celgene" with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Mesoblast, Inc." with 2 trials sponsored and "Pharmasset" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nashville Gastrointestinal Specialists Inc." #1 collaborator was "Novartis" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Nashville Gastrointestinal Specialists Inc." are "Hepatitis C, Chronic" (5 trials), "Chronic Hepatitis C" (4 trials), "Hepatitis C Virus Infection" (3 trials), "Chronic Hepatitis" (2 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Nashville Gastrointestinal Specialists Inc." in a lesser frequency.

Most popular intervention types in "Nashville Gastrointestinal Specialists Inc." are "Drug" (23 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "RBV" (8 trials), "Placebo" (5 trials), "Sofosbuvir" (4 trials), "SOF" (3 trials) and "AQUAVAN® (fospropofol disodium) Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nashville Gastrointestinal Specialists Inc." are 24 trials for "All" genders.

Currently, there are NaN active trials in "Nashville Gastrointestinal Specialists Inc.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Nashville Gastrointestinal Specialists Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nashville Gastrointestinal Specialists Inc., 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".